Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen R Laird

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|February 17, 2012
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic propertiesSimon Mathieu, Stefan N Gradl, Li Ren, et al.
Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.
Cancer Discovery|June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted TherapyAlexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitorsMichael A Letavic, Matt Z Axt, John T Barberia, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14Julian A Blagg, Mark C Noe, Lilli A Wolf-Gouveia, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2006
Potent, selective pyrimidinetrione-based inhibitors of MMP-13Lawrence A Reiter, Kevin D Freeman-Cook, Christopher S Jones, et al.
Journal of Medicinal Chemistry|January 25, 2007
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activityDerin C D'Amico, Toshi Aya, Jason Human, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13Kevin D Freeman-Cook, Lawrence A Reiter, Mark C Noe, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical developmentKim F McClure, Michael A Letavic, Amit S Kalgutkar, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious InhibitorsSteve Wenglowsky, Li Ren, Kateri A Ahrendt, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|February 17, 2012
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic propertiesSimon Mathieu, Stefan N Gradl, Li Ren, et al.
Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.
Cancer Discovery|June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted TherapyAlexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitorsMichael A Letavic, Matt Z Axt, John T Barberia, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14Julian A Blagg, Mark C Noe, Lilli A Wolf-Gouveia, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2006
Potent, selective pyrimidinetrione-based inhibitors of MMP-13Lawrence A Reiter, Kevin D Freeman-Cook, Christopher S Jones, et al.
Journal of Medicinal Chemistry|January 25, 2007
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activityDerin C D'Amico, Toshi Aya, Jason Human, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13Kevin D Freeman-Cook, Lawrence A Reiter, Mark C Noe, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical developmentKim F McClure, Michael A Letavic, Amit S Kalgutkar, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious InhibitorsSteve Wenglowsky, Li Ren, Kateri A Ahrendt, et al.
Pageof 4